Here's a nice summary of the clinical trials for Neuronomics in peer reviewed journals.
For sufferers of tinnitus, the condition described as ringing in the ears
when no external sounds are present, treatment and relief have been
elusive and inconsistent. Now, Neuromonics, Inc., has issued a
comprehensive clinical summary of results to help tinnitus sufferers and
providers understand that they can obtain effective treatment.
manufactures and distributes the only FDA-cleared, patented and
clinically proven medical device designed for long-term significant
relief of tinnitus. Clinically administered and monitored, the
Neuromonics Tinnitus Treatment uses the non-invasive device, customized
to each patient’s individual audiological profile, to deliver a neural
stimulus that targets the brain’s auditory pathways.
The clinical summary (PDF), is available at Neuromonics’ website, or by requesting a copy by e-mailing email@example.com.
The summary includes detailed results of Neuromonics Tinnitus
Treatment’s clinical efficacy as presented in papers appearing in
peer-reviewed medical journals. In addition, the summary outlines nine
additional studies that researchers have presented at medical meetings
throughout the United States and Europe. Each provides additional
evidence of clinical efficacy.